Abstract

Perianal disease is a particularly morbid phenotype of Crohn's disease with significantly diminished quality of life, affecting up to a third of patients. Medical therapies achieve long term durable remission in only a third of patients. Thus, most undergo operative intervention, at the expense of a risk of incontinence. Mesenchymal stem cell therapy is an emerging therapy without risk of incontinence and improved efficacy as compared to conventional therapy. Additional manifestations of perianal Crohn's disease including hemorrhoids and skin tags are possible to manage operatively, only in the absence of proctitis and anal canal disease.

Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.